Literature DB >> 20399249

Mutation analysis of parkin and PINK1 genes in early-onset Parkinson's disease in China.

Bao-rong Zhang1, Zheng-xiang Hu, Xin-zhen Yin, Miao Cai, Guo-hua Zhao, Zhi-rong Liu, Wei Luo.   

Abstract

A series of 69 Han Chinese PD patients (including 66 index cases and 3 relatives) with early-onset Parkinson's disease (EOPD) were studied to assess the frequency of parkin and PINK1 gene mutations. Mutation analysis of the parkin gene was performed by real-time quantitative polymerase chain reaction (QPCR), denaturing high-performance liquid chromatography (DHPLC) and DNA sequencing. For the PINK1 gene, DHPLC and DNA sequencing were used. Nineteen patients (including one relative) had mutation in the parkin gene, and the c.2T > C (p.M1T) was not reported previously. No mutation of the PINK1 gene was found. The onset age of the patients with mutations in the parkin was earlier than that of those without mutation (p < 0.05). We concluded that mutations in parkin gene are common in Chinese EOPD patients, and mainly are exon rearrangements, while mutation in PINK1 might be not common in Chinese EOPD patients. 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20399249     DOI: 10.1016/j.neulet.2010.04.026

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  Analysis of Dosage Mutation in PARK2 among Korean Patients with Early-Onset or Familial Parkinson's Disease.

Authors:  Min Kyung Chu; Won Chan Kim; Jung Mi Choi; Jeong-Hoon Hong; Suk Yun Kang; Hyeo-Il Ma; Yun Joong Kim
Journal:  J Clin Neurol       Date:  2014-07-03       Impact factor: 3.077

2.  Aberrant proteins expressed in skin fibroblasts of Parkinson's disease patients carrying heterozygous variants of glucocerebrosidase and parkin genes.

Authors:  Phannee Sawangareetrakul; Lukana Ngiwsara; Voraratt Champattanachai; Daranee Chokchaichamnankit; Kittirat Saharat; James R Ketudat Cairns; Chantragan Srisomsap; Kawinthra Khwanraj; Permphan Dharmasaroja; Teeratorn Pulkes; Jisnuson Svasti
Journal:  Biomed Rep       Date:  2021-02-17

Review 3.  Disruption of Mitochondrial Homeostasis: The Role of PINK1 in Parkinson's Disease.

Authors:  Maria Vizziello; Linda Borellini; Giulia Franco; Gianluca Ardolino
Journal:  Cells       Date:  2021-11-04       Impact factor: 6.600

4.  Genetic analysis of PARK2 and PINK1 genes in Brazilian patients with early-onset Parkinson's disease.

Authors:  Karla Cristina Vasconcelos Moura; Mário Campos Junior; Ana Lúcia Zuma de Rosso; Denise Hack Nicaretta; João Santos Pereira; Delson José Silva; Flávia Lima dos Santos; Fabíola da Costa Rodrigues; Cíntia Barros Santos-Rebouças; Márcia Mattos Gonçalves Pimentel
Journal:  Dis Markers       Date:  2013-08-14       Impact factor: 3.434

5.  T313M polymorphism of the PINK1 gene in Parkinson's disease.

Authors:  Qin Luo; Xinling Yang; Yani Yao; Hongjuan Li; Yuling Wang
Journal:  Exp Ther Med       Date:  2014-05-08       Impact factor: 2.447

Review 6.  Mouse Genetic Models of Human Brain Disorders.

Authors:  Celeste Leung; Zhengping Jia
Journal:  Front Genet       Date:  2016-03-23       Impact factor: 4.599

7.  Whole exome sequencing identified a new compound heterozygous PRKN mutation in a Chinese family with early-onset Parkinson's disease.

Authors:  Tianbai Li; Daqing Kou; Yanhua Cui; Weidong Le
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

Review 8.  C-terminus of Hsp70 Interacting Protein (CHIP) and Neurodegeneration: Lessons from the Bench and Bedside.

Authors:  Sivakami Mylvaganam; Rebecca Earnshaw; Gregory Heymann; Suneil K Kalia; Lorraine V Kalia
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.